Low‐dose combined oral contraceptives
- 1 December 1994
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 101 (12), 1036-1041
- https://doi.org/10.1111/j.1471-0528.1994.tb13578.x
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrelActa Obstetricia et Gynecologica Scandinavica, 1992
- Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiolActa Obstetricia et Gynecologica Scandinavica, 1992
- Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimateActa Obstetricia et Gynecologica Scandinavica, 1992
- Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical TrialsActa Obstetricia et Gynecologica Scandinavica, 1990
- A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular DiseasesNew England Journal of Medicine, 1988
- A comparison of the effects of two triphasic oral contraceptives on haemostasisBritish Journal of Haematology, 1988
- Comparative Trial of the Effects on Glucose Tolerance and Lipoprotein Metabolism of two New Oral Contraceptives Containing Gestoden and DesogestrelActa Obstetricia et Gynecologica Scandinavica, 1988
- Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- A Clinical Comparison in Finland of Two Oral Contraceptives Containing 0.150 mg Desogestrel in Combination with 0.020 mg Or 0.030 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- PULMONARY EMBOLISMThe Lancet, 1961